SAURARA
"Idan muna son wani abu tabbatacce, zai dauki lokaci mai tsawo. Idan muna son wani abu da sauri, dole ne mu yarda cewa za su zama alamun rashin lafiya. Gaskiyar ita ce, akwai allurar rigakafin coronavirus, a zahiri, kafin shekaru biyu ban yi imani da shi ba. "
Dokta Pedro Cavadas ya yi gargadin hadarin da ke tattare da gudanar da alluran rigakafin cutar sankara a cikin lokacin rikodin lokacin da har yanzu ba a yi allurar ko guda daya a duk duniya ba. Ya kasance Oktoba 2020. Dangane da lissafin likitan fiɗa, wanda shine ɗaya daga cikin muryoyin farko a cikin al'ummar kimiyyar Sipaniya don yin gargaɗi game da haɗarin ƙwayar cuta, don samun cikakkiyar rigakafin "lafiya da inganci", da zai yi. ya zama dole a jira har faɗuwar wannan shekara.
Bukatar dakatar da cutar sankara ta coronavirus ta haifar da gabatar da allurar rigakafin cutar coronavirus da wuri fiye da yadda tsarin ilimin likitanci ya kafa, kamar yadda Pedro Cavadas ya bayyana, ya kafa matakai daban-daban guda uku kafin bayyanar su.
Kodayake akwai yarjejeniya game da ingancin alluran rigakafin cutar coronavirus daban-daban don rage illar kamuwa da cuta, gaskiyar ita ce tun lokacin da aka fara alluran rigakafin farko, mummunan tasirin ya yaɗu akan waɗanda suka yaudari likitan Valencian.
Pedro Cavadas an yi masa allurar rigakafi kuma ya ƙaddamar da sukar sa game da masu musun coronavirus
Dangane da wannan, sabbin bincike kan illolin allurar rigakafin coronavirus sun tabbatar da abubuwan Pedro Cavadas. Wannan shi ne batun rahoton da Jami'ar Kiwon Lafiya ta Kaohsiung da ke Taiwan ta shirya kuma 'Journal of Clinical Medicine' ta buga.
Binciken da ƙwararrun Asiya suka yi ya haɗa allurar rigakafin Covid-19 tare da sabon sakamako na gefe: Ciwon OAB, wanda kuma aka sani da mafitsara mai yawan aiki.
Nazarin da jami'ar Taiwan ta gudanar ya nuna cewa waɗanda aka yiwa alluran alluran Pfizer, Astrazeneca ko Moderna a kan coronavirus na iya samun ɗan ƙaramin tasiri. Wadannan sun hada da zazzabi, gudawa, da amai.
A wannan yanayin na ƙasarmu, sabis na kula da magunguna na Hukumar Kula da Magunguna da Kayayyakin Lafiya ta Spain (Aemps) ta karɓi sanarwar 70.965 na abubuwan da suka faru da suka shafi rigakafin cutar coronavirus har zuwa watan Mayun da ya gabata.
Rahoton WHO na baya-bayan nan game da alluran rigakafi
Baya ga gargadin Pedro Cavadas game da halayen da allurar rigakafin coronavirus na iya haifarwa, likitan Valencian ya kuma yi gargadin cewa alluran rigakafin cutar za su dauki "shekaru da yawa" don isa ga daukacin al'ummar duniya. Ta haka ne sabbin rahotannin da Hukumar Lafiya ta Duniya (WHO) ta fitar sun tabbatar da haka.
Don haka, bisa ga karshen taron lafiya na duniya karo na 75 da aka gudanar a birnin Geneva, kasashe 57 ne kawai a duniya - wadanda suka fi yawan masu matsakaicin kudin shiga ko na sama - suka yi allurar kashi saba'in na mazaunansu. Akasin haka, kamar yadda Pedro Cavadas ya yi gargadin, kusan mutane biliyan daya a kasashe masu karamin karfi ba su sami rigakafin ba tukuna.
Batun kasar Sin ya cancanci a ambace shi na dabam, inda rashin yin allurar rigakafin cutar ga rukunin mutanen da suka haura shekaru sittin da kuma nakasu a cikin alluran rigakafinta ya sa hukumominta suka zartar da wasu da dama wadanda ke tunawa da wadanda gwamnatin Spain ta aiwatar a shekarar 2022.
A wannan yanayin, akwai juyin halittar asymmetric na tsarin rigakafin da ke ba da wahala a kawar da coronavirus, Dr. Pedro Cavadas ya annabta ta misali, ya karɓi maganin cutar ta covid (a cikin yanayinsa na Moderna) kuma ya ƙaddamar da sukar mai zafi. masu musanta coronavirus.
Waɗannan su ne manyan illolin allurar coronavirus
Illolin da ke tattare da yawan sanarwar bayan huda na uku na rigakafin Pfizer a kan coronavirus sune:
- Lymphadenopathy (kumburi gland) (30%)
-Pyrexia (fiber) (20%)
- Ciwon kai (10%)
Myalgia (8%)
- Rashin jin daɗi (7%)
-Gajiya (6%)
-Ciwo a yankin hutu (4%)
-Sannan (4%)
-Arthralgia (ciwon haɗin gwiwa) (3%)
-Axillary Pain (3%)
Abubuwan da aka fi bayar da rahoto bayan gudanar da allura na uku na allurar Moderna sune:
-Pyrexia (34%)
- Ciwon kai (18%)
- Lymphadenopathy (16%)
Myalgia (12%)
- Rashin jin daɗi (9%)
-Ciwo a yankin hutu (9%)
- Tashin zuciya (8%)
-Gajiya (8%)
-Arthralgia (7%)
-Sannan (6%)
